Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
CYTK holding history
Cytokinetics Inc in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings
- Shares (Q2 2026)
- 30,000
- Value
- $2.56M
- % of portfolio
- 1.2%
- Quarters held
- 21
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 30,000 | $2.56M | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 30,000 | $1.98M | 1.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 30,000 | $1.91M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 30,000 | $1.65M | 1.2% | +20,000+200.0% | Added | Holders |
| Q2 2025 | 10,000 | $330.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,000 | $401.9K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $470.4K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,000 | $528.0K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,000 | $541.8K | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,000 | $701.1K | 0.6% | −15,000−60.0% | Reduced | Holders |
| Q4 2023 | 25,000 | $2.09M | 1.6% | 00.0% | Unchanged | Holders |
| Q3 2023 | 25,000 | $736.5K | 0.6% | 00.0% | Unchanged | Holders |
| Q2 2023 | 25,000 | $815.5K | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2023 | 25,000 | $880.0K | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2022 | 25,000 | $1.15M | 0.8% | 00.0% | Unchanged | Holders |
| Q3 2022 | 25,000 | $1.21M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2022 | 25,000 | $982.0K | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2022 | 25,000 | $920.0K | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2021 | 25,000 | $1.14M | 0.7% | 00.0% | Unchanged | Holders |
| Q3 2021 | 25,000 | $894.0K | 0.6% | +15,000+150.0% | Added | Holders |
| Q2 2021 | 10,000 | $198.0K | 0.1% | +10,000 | New | Holders |